pregnancy Archives

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

The Case of Cannabinoid Hyperemesis Syndrome Associated with Helicobacter Pylori and Pre-Eclampsia in Pregnancy

Madeline Manning Meurer, MD; Kalyan Chakrala, MD; Dinesh Gowda, MD; Charles Burns, MD; Randall Kelly, MD; & Natalia Schlabritz-Loutsevitch, MD, PhD

Substance Abuse Vol. 39, Iss. 1, 2018

“There is the urgent need to study the effects of cannabis use in pregnant women, particularly considering the fact that no US states provide guidelines on the possible harmful effects of marijuana use during pregnancy. The use of substance abuse during pregnancy could be masked by pregnancy-specific complications. In particular, cannabinoid hyperemesis syndrome (CHS), described in chronic cannabis users, represents a challenging diagnosis in pregnancy. The described case adds to the published few cases of CHS in pregnant women. This case raises awareness of the health care providers to the timely diagnosis of complications of marijuana use in pregnancy and provides possible link of marijuana use to pre-eclampsia and H. Pylori colonization.”

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Barriers to Accessing Treatment for Pregnant Women with Opioid Use Disorder in Appalachian States

Stephen W. Patrick MD, MPH, MS; Melinda B. Buntin PhD; Peter R. Martin MD, MSc; Theresa A. Scott MS,William Dupont PhD; Michael Richards MD, PhD; & William O. Cooper MD, MPH

Substance Abuse Vol. 40, Iss. 3, 2019

“In a survey of opioid agonist treatment (OAT) providers in Appalachia, we found that providers frequently did not accept any insurance and frequently did not treat pregnant women in an area of the country disproportionately affected by the opioid epidemic. Policymakers could prioritize improvements in provider training, including training of obstetricians to become buprenorphine prescribers, as a means to enhance access to pregnant women or enhancing reimbursement rates as a means of improving insurance acceptance for OAT.”

The Authors’ Own Words: The Case of Cannabinoid Hyperemesis Syndrome Associated with Helicobacter Pylori and Pre-Eclampsia in Pregnancy

The Authors’ Own Words: Barriers to Accessing Treatment for Pregnant Women with Opioid Use Disorder in Appalachian States